Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Hinz, Michael Dr. (1) Kammertöns, Thomas Dr. (1) Kieback, Elisa Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Rajewsky, Nikolaus Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (1) Selbach, Matthias Prof. Dr. (8) Uckert, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (2) Wollert-Wulf, Brigitte (2) (-) Blankenstein, Thomas Prof. Dr. (11) (-) Janz, Martin Dr. (6) (-) Lusatis, Simone (1) (-) Mathas, Stephan Dr. (9) (-) Biologie maligner Lymphome (10) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (11) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (4) 2000 (10) (-) 2001 (6) 2002 (11) 2003 (12) 2004 (11) 2005 (13) (-) 2006 (6) 2007 (9) (-) 2008 (9) 2009 (6) 2010 (10) 2011 (9) 2012 (8) 2013 (14) 2014 (6) 2015 (8) 2016 (7) 2017 (11) 2018 (5) 2019 (8) 2020 (6) 2021 (7) 2022 (13) 2023 (14) 2024 (4) 21 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Janz, Martin Dr.Lusatis, SimoneMathas, Stephan Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 200120062008 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 2001 / Nat Med Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay C. Becker H. Pohla B. Frankenberger T. Schueler M. Assenmacher D.J. Schendel T. Blankenstein 03. Dezember 2001 / J Exp Med Tumor rejection by disturbing tumor stroma cell interactions S. Ibe Z.H. Qin T. Schueler S. Preiss T. Blankenstein 17. Dezember 2001 / J Exp Med Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8+ T cells T. Schueler T. Kammertoens S. Preiss P. Debs N. Noben-Trauth T. Blankenstein 01. Januar 2001 / Canc Res Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber 01. Januar 2001 / Eur J Immunol Decreased generation of anti-tumor immunity after intrasplenic immunization S. Cayeux Z.H. Qin B. Doerken T. Blankenstein 01. Januar 2001 / Blood Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells M. Hinz P. Loeser S. Mathas D. Krappmann B. Dörken C. Scheidereit 01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Januar 2001 / Nat Med Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay C. Becker H. Pohla B. Frankenberger T. Schueler M. Assenmacher D.J. Schendel T. Blankenstein
03. Dezember 2001 / J Exp Med Tumor rejection by disturbing tumor stroma cell interactions S. Ibe Z.H. Qin T. Schueler S. Preiss T. Blankenstein
17. Dezember 2001 / J Exp Med Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8+ T cells T. Schueler T. Kammertoens S. Preiss P. Debs N. Noben-Trauth T. Blankenstein
01. Januar 2001 / Canc Res Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber
01. Januar 2001 / Eur J Immunol Decreased generation of anti-tumor immunity after intrasplenic immunization S. Cayeux Z.H. Qin B. Doerken T. Blankenstein
01. Januar 2001 / Blood Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells M. Hinz P. Loeser S. Mathas D. Krappmann B. Dörken C. Scheidereit
01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel